CVS Health president and CEO Larry Merlo made the announcement alongside Rhode Island Gov. Gina Raimondo at the 2017 National Governor’s Association Summer Meeting, where Merlo has been touting the company’s approach to providing accessible and effective care.
The program would restore access to chain and independent pharmacies for TRICARE beneficiaries, who currently have to obtain non-generic medications through mail-order pharmacies or military treatment facilities.
Along with the new indication, the Food and Drug Administration DA approved a next-generation sequencing-based test to identify the RAS mutation status of a patient’s tumor, which Amgen said helps identify patients who would benefit from treatment with Vectibix.
The agency has outlined its Orphan Drug Modernization plan, which it said is part of a larger effort called the Medical Innovation Development plan modernize and make efficient the FDA’s regulatory tools and policies.
The National Association of Chain Drug Stores and the American Pharmacists Association shared their concerns with the Trump Administration about the potential impact of drug importation on patient safety and the delivery of value-based care.
Since 2011, 68 novel therapies have been approved globally across 22 cancer indications. The QunitilesIMS Institute report looks at what technological advances and development trends have made this possible, as well as their cost.